Charles J. Hall - 28 Oct 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Group President
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
28 Oct 2022
Net transactions value
-$3,372,770
Form type
4
Filing time
01 Nov 2022, 18:32:22 UTC
Previous filing
23 Feb 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $925,614 +9,150 +4.5% $101.16 210,788 28 Oct 2022 Direct
transaction HCA Common Stock Options Exercise $3,058,903 +21,997 +10% $139.06 232,785 28 Oct 2022 Direct
transaction HCA Common Stock Tax liability $5,158,494 -23,064 -9.9% $223.66 209,721 28 Oct 2022 Direct
transaction HCA Common Stock Sale $2,198,793 -9,838 -4.7% $223.50 199,883 28 Oct 2022 Direct
holding HCA Common Stock 4,525 28 Oct 2022 By 2021 Family GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -9,150 -100% $0.000000* 0 28 Oct 2022 Common Stock 9,150 $101.16 Direct F1
transaction HCA Stock Appreciation Right Options Exercise $0 -21,997 -75% $0.000000 7,333 28 Oct 2022 Common Stock 21,997 $139.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
F2 The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020.